$294 Million is the total value of Stellar Capital Management, LLC's 151 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VWO | Sell | Vanguard Emerging Markets Stock ETFftse emr mkt etf | $4,784,000 | +14.4% | 118,837 | -4.6% | 1.58% | -54.0% |
| ABT | Sell | Abbott Laboratories | $336,000 | +8.4% | 3,680 | -6.4% | 0.11% | -56.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intel Corporation | 26 | Q2 2020 | 5.6% |
| Merck & Company, Inc. | 26 | Q2 2020 | 4.0% |
| Vanguard Emerging Markets Stock ETF | 26 | Q2 2020 | 3.7% |
| BlackRock, Inc. | 26 | Q2 2020 | 3.5% |
| Microsoft Corporation | 26 | Q2 2020 | 5.0% |
| Johnson & Johnson | 26 | Q2 2020 | 3.2% |
| Thermo Fisher Scientific | 26 | Q2 2020 | 3.1% |
| SPDR DB Intl Govt Infl-Protected Bond | 26 | Q2 2020 | 4.5% |
| Procter & Gamble | 26 | Q2 2020 | 2.6% |
| Global Payments, Inc. | 26 | Q2 2020 | 2.7% |
View Stellar Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2020-08-17 |
| 13F-HR | 2020-08-17 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-26 |
| 13F-HR | 2019-11-18 |
| 13F-HR | 2019-08-16 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-19 |
| 13F-HR | 2018-11-13 |
| 13F-HR | 2018-08-07 |
View Stellar Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.
Compare quarters
The following issues were detected while analyzing the report:
- The reported total value is incorrect (294234000.0 != 302454000.0)
- The reported number of holdings is incorrect (151 != 154)
- The reported has been restated
- The reported has been amended
Export Stellar Capital Management, LLC's holdings